Baxter International Inc. also reported some encouraging results in July from its potential Alzheimer’s treatment, Gammagard. The company said a tiny study indicated Gammagard might help stabilize Alzheimer’s for up to three years. Four patients who got the highest dose of Gammagard for three years showed no decline on memory and cognition tests, but a dozen others on different doses or shorter treatment times didn’t fare as well.
That study was too small to prove the treatment works, but a more rigorous one involving 400 patients will end late this year with results expected by early next year.
By Elaine Donnelly
Extending sexual misconduct to combat units
Independent voices from the TWT Communities
An establishmentarian conservative, short on cash, but long on wisdom.
First over-the-counter column approved for fast and effective relief from even your worst media-induced headache.
A collection of reader guest articles, thoughts and opinions by Communities writers and breaking news and information.
Benghazi: The anatomy of a scandal
Vietnam Memorial adds four names
Cinco de Mayo on the Mall
NRA kicks off annual convention